CTRI/2023/12/060803招募中2 期
Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial): A Randomized control trial. - NORRIF
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Age >18 years
- •2) Cirrhosis (of any etiology) with ascites
- •3) Prior incident SBP
排除标准
- •1.Allergy to norfloxacin or rifaximin
- •2.Recent history of upper gastrointestinal bleed (UGIB) within 2 weeks
- •3.Patients with a history of multiple episodes of SBP
- •4.Patients with inoperable or not treatable HCC or other non-hepatic malignancy
- •5.Patients on immunosuppression
- •6.HIV infected
- •7.Post liver transplant
- •8.Recent ( <6 months) abdominal surgery
- •9.Pregnant/lactating women
- •10.Other causes of ascites like tubercular or malignancy
- •11.Patients developing SBP on Norfloxcacin
研究者
相似试验
Unknown
3 期
Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial PeritonitisSpontaneous Bacterial PeritonitisAscitesLiver CirrhosisNCT02120196Sherief Abd-Elsalam100
招募中
不适用
Efficacy and safety of Rifaximin for the treatment of liver cirrhosis with covert hepatic encephalopathyiver cirrhosisJPRN-UMIN000044657Wakayama Medical University40
已完成
3 期
The therapeutic effects of rifaximin in diarrhea-predominant irritable bowel syndromediarrhea-predominant irritable bowel syndrome.K58.0Irritable bowel syndrome with diarrheaIRCT20141201020178N12Iran University of Medical Sciences150
进行中（未招募）
不适用
Effects of rifaximin administration in patients with severe acute alcoholic hepatitis. Comparative pilot study.EUCTR2012-000515-80-ESJuan Córdoba
招募中
2 期
Prospective study on suppression of cholangitis using rifaximin after SEMS placement for distal malignant biliary obstructioJPRN-jRCTs051210173Ikezawa Kenji30